BSE filing, NSE: JLHL. Summary written from the filing by ALFA Finder's alert engine.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹287.60
- Market cap
- ₹9,428 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 50.6×Sector 53.9×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Jupiter Lifeline reports strong growth with Q2 revenue of ₹456.5 Cr and EBITDA of ₹106.9 Cr. Management prioritizes asset ownership, recently acquiring the Pune South hospital land for ₹150 Cr.
Jupiter Life Line Hospitals Acquisition Worth ₹150 Cr
Jupiter Life Line Hospitals executed a sale agreement to acquire 11,452.07 sq m of land in Pune for Rs 150 Crore. The land is where its South Pune hospital project is under development.
- Value
- ₹150.0 Cr
Jupiter Life Line Hospitals Capacity Expansion: ₹0.01 Cr Investment
Jupiter Life Line Hospitals will hold 100% of newly incorporated subsidiary Holitti Private Limited, a healthcare services entity. The subscription is for paid-up capital of Rs 1,00,000, about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Merger & Restructuring Worth ₹0.01 Cr
Jupiter Life Line Hospitals will incorporate wholly owned subsidiary Holitti Private Limited for healthcare services, subscribing Rs 1 lakh. It will run laboratory and healthcare services.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 436.3 cr (+15.8% YoY), EBITDA Rs 106.9 cr (23.4% margin), PAT Rs 56.4 cr (-1.7%) on Dombivli ramp-up, depreciation and finance costs. Bed capacity expanding from 1,700 to 2,900.
Jupiter Life Line Hospitals Q2 FY27 Results: Net Profit ₹56.4 Cr, Down 1.9% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹456.5 Cr (+16.0% YoY) and net profit of ₹56.4 Cr (-1.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.4 Cr · -1.9% YoY
Other management change announcements
All →Axiom Gas Engineering Management Change
Axiom Gas appointed Kinnari Patel as Whole-time Director for five years from 7 November 2026. Shareholder approval is still required.
- Execution
- Five years from 07 November 2026, subject to shareholder approval
Kirloskar Industries Management Change
Kirloskar Ferrous Industries, a listed material subsidiary, appointed Ajay Shriram Patil as Director and Joint Managing Director for three years. The joint managing director term takes effect from September.
- Execution
- Three years
Wardwizard Innovations & Mobility Management Change
Wardwizard Innovations & Mobility Limited has appointed Mr. Vishal Manharbhai Shah as Non-Executive Independent Director, effective 7 November 2026. He is a practising Cost Accountant with cost audit and financial analysis expertise.
Fratelli Vineyards Management Change
Fratelli Vineyards appointed Avinash Gautam Thadani as Non-Executive Independent Director for 60 months from November 7, 2026. The appointment was approved at a board meeting that day.
- Execution
- 60 months
Aastha Spintex Management Change
Aastha Spintex Limited reports the cessation of Mr. Jashwantvaljibhai Patel as Executive Director, effective 6 November 2026, due to demise. The change is a Management Change event.
Suprajit Engineering Management Change
Suprajit Engineering's board recommends appointing Dr. Steffen Berns as a Non-Executive Independent Director for three years from 1 January 2027. Shareholder approval by postal ballot is pending.